Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Rubens

Showing results (161-170 of 212) with videos related to

Pageof 22
Sort By:
International Journal of Cancer|March 15, 1994
Expression of tumour necrosis factor (TNF alpha) and its receptors in benign and malignant breast tissueD W Miles, L C Happerfield, M S Naylor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1990
Node-negative breast cancer: prognostic subgroups defined by tumor size and flow cytometryS M O'Reilly, R S Camplejohn, D M Barnes, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Psychiatric disorder in patients with advanced breast cancer: prevalence and associated factorsK L Pinder, A J Ramírez, M E Black, et al.
Cancer Chemotherapy and Pharmacology|July 31, 1998
Doxorubicin pharmacokinetics: the effect of abnormal liver biochemistry testsC J Twelves, N A Dobbs, H C Gillies, et al.
BMJ (Clinical Research Ed.)|February 4, 1989
Stress and relapse of breast cancerA J Ramirez, T K Craig, J P Watson, et al.
British Journal of Cancer|December 1, 1994
Expression of sialyl-Tn predicts the effect of adjuvant chemotherapy in node-positive breast cancerD W Miles, L C Happerfield, P Smith, et al.
Surgery|March 1, 1984
A new combined approach to the conservative treatment of early breast cancerJ L Hayward, P J Winter, D Tong, et al.
BMJ (Clinical Research Ed.)|January 4, 1992
Appropriate chemotherapy for palliating advanced cancerR D Rubens, K E Towlson, A J Ramirez, et al.
Endocrine-Related Cancer|March 19, 2004
The interaction of oestrogen receptor status and pathological features with adjuvant treatment in relation to survival in patients with operable breast cancer: a retrospective study of 2660 patientsD M Barnes, R R Millis, C E Gillett, et al.
British Journal of Cancer|October 1, 1996
A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancerD W Miles, K E Towlson, R Graham, et al.
Pageof 22

Showing results (161-170 of 212) with videos related to

Sort By:
Pageof 22
International Journal of Cancer|March 15, 1994
Expression of tumour necrosis factor (TNF alpha) and its receptors in benign and malignant breast tissueD W Miles, L C Happerfield, M S Naylor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1990
Node-negative breast cancer: prognostic subgroups defined by tumor size and flow cytometryS M O'Reilly, R S Camplejohn, D M Barnes, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Psychiatric disorder in patients with advanced breast cancer: prevalence and associated factorsK L Pinder, A J Ramírez, M E Black, et al.
Cancer Chemotherapy and Pharmacology|July 31, 1998
Doxorubicin pharmacokinetics: the effect of abnormal liver biochemistry testsC J Twelves, N A Dobbs, H C Gillies, et al.
BMJ (Clinical Research Ed.)|February 4, 1989
Stress and relapse of breast cancerA J Ramirez, T K Craig, J P Watson, et al.
British Journal of Cancer|December 1, 1994
Expression of sialyl-Tn predicts the effect of adjuvant chemotherapy in node-positive breast cancerD W Miles, L C Happerfield, P Smith, et al.
Surgery|March 1, 1984
A new combined approach to the conservative treatment of early breast cancerJ L Hayward, P J Winter, D Tong, et al.
BMJ (Clinical Research Ed.)|January 4, 1992
Appropriate chemotherapy for palliating advanced cancerR D Rubens, K E Towlson, A J Ramirez, et al.
Endocrine-Related Cancer|March 19, 2004
The interaction of oestrogen receptor status and pathological features with adjuvant treatment in relation to survival in patients with operable breast cancer: a retrospective study of 2660 patientsD M Barnes, R R Millis, C E Gillett, et al.
British Journal of Cancer|October 1, 1996
A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancerD W Miles, K E Towlson, R Graham, et al.
Pageof 22